Chongqing Zhifei Biological Products Co Ltd
300122
Company Profile
Business description
Chongqing Zhifei Biological Products Co Ltd is engaged in research and development, production, and sales of vaccines and biological products. The company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevention and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus, and other viruses, general drugs and other biological products, among others.
Contact
No. 1, Qingyun Road
50th Floor, Building T1, IFC Center
Jiangbei District
Chongqing400020
CHNT: +86 2386358226
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
7,220
Stocks News & Analysis
stocks
10 best global blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalizations look undervalued today.
stocks
3 overvalued ASX shares going into earnings
Prices of these shares exceed our Fair Value Estimate by more than double.
stocks
The long-term case for compounders
Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,068.80 | 42.20 | -0.46% |
| CAC 40 | 8,191.78 | 65.25 | 0.80% |
| DAX 40 | 24,754.72 | 215.91 | 0.88% |
| Dow JONES (US) | 48,882.64 | 9.83 | -0.02% |
| FTSE 100 | 10,332.80 | 109.26 | 1.07% |
| HKSE | 26,775.57 | 611.54 | -2.23% |
| NASDAQ | 23,413.15 | 48.66 | -0.21% |
| Nikkei 225 | 52,655.18 | 667.67 | -1.25% |
| NZX 50 Index | 13,412.44 | 10.74 | -0.08% |
| S&P 500 | 6,929.80 | 9.23 | -0.13% |
| S&P/ASX 200 | 8,778.60 | 42.50 | -0.48% |
| SSE Composite Index | 4,015.75 | 102.20 | -2.48% |